BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2499263)

  • 21. [Detection of placental alkaline phosphatase in ovarian cancer].
    Wang R; Song L; Ding L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):107-9. PubMed ID: 8758806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
    Ryuko K; Iwanari O; Kitao M; Moriwaki S
    Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical application of cancer-associated carbohydrate antigens in the diagnosis and therapy of human cancers].
    Kannagi R; Shigeta K; Hirashima K; Takada A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1157-66. PubMed ID: 2658813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
    Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
    Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and clinical evaluation of tumor-associated antigen CA54/61 identified by monoclonal antibodies MA54 and MA61 in epithelial ovarian cancer.
    Kobayashi H; Ohi H; Sugimura M; Shinohara H; Terao T
    Gynecol Oncol; 1992 Dec; 47(3):328-36. PubMed ID: 1473746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
    Shi ZL
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR; Wang EY; Wang XX; Jia XH; Li L
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids.
    Uemura M; Sakaguchi T; Uejima T; Nozawa S; Narimatsu H
    Cancer Res; 1992 Nov; 52(22):6153-7. PubMed ID: 1423258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.
    Fisken J; Leonard RC; Roulston JE
    Dis Markers; 1989; 7(1):61-7. PubMed ID: 2653700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of a tumor marker (CA54/61) and its individual epitopes recognized by monoclonal antibodies, MA54 and MA61, in human tumor patients.
    Mochizuki H; Nagoya K; Yamauchi T; Takao Y; Masuko H; Sato H; Sasaki H; Itoh K; Tsukazaki K; Udagawa Y
    J Clin Lab Anal; 1992; 6(4):225-31. PubMed ID: 1383482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monoclonal antibodies raised against cultured cells and their application in cancer diagnosis].
    Nozawa S; Udagawa Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1858-63. PubMed ID: 2730079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR; Pletsch QA; Goldenberg DM
    Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new monoclonal antibody (SH-9) recognizes the low molecular mass of ovarian cancer antigen CA125].
    Maeda H; Imai S; Morimoto J; Kiyozuka Y; Noda T; Haga S; Hiroishi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):320-6. PubMed ID: 1694212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunoassay of placental alkaline phosphatase in ovarian cancer sera and tissues.
    Mano H; Furuhashi Y; Morikawa Y; Hattori SE; Goto S; Tomoda Y
    Obstet Gynecol; 1986 Dec; 68(6):759-64. PubMed ID: 3024085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A fundamental and clinical investigation of cancer antigen 130 (CA 130) in the field of obstetrics and gynecology].
    Inaba N; Okajima Y; Ota Y; Fukazawa I; Yamaguchi T; Sato N; Sudo H; Milanga M; Takamizawa H; Fujii S
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2426-35. PubMed ID: 2614181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
    Nozawa S; Yajima M; Sakuma T; Udagawa Y; Kiguchi K; Sakayori M; Narisawa S; Iizuka R; Uemura M
    Cancer Res; 1990 Feb; 50(3):754-9. PubMed ID: 2105162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application of multi-tumor markers in ovarian carcinoma].
    Feng J; Qian H; Tian Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 May; 33(5):284-6. PubMed ID: 10682440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2535-6. PubMed ID: 10470190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.